Correction, Tuesday March 16, 4:00 p.m. EDT—Earlier today, we reported that during a March 16 webinar, advisers to 340B covered entities said that U.S. Rep. Abigail Spanberger (D-Va.) had written to pharmacy benefit manager Express Scripts (ESI) about its new claims identification requirement for 340B drugs. According to a spokesperson for Spanberger, while it is true that the congresswoman’s staff has been in close contact with 340B covered entity organizations to explore the implications of Express Scripts’ actions on 340B covered entities, a letter has not been sent from Spanberger’s office to Express Scripts. 340B Report regrets the error.
Legislation addressing pharmacy benefit manager Express Scripts’ (ESI) new claims identification requirement for 340B drugs could be introduced in Congress soon, advisers to 340B covered entities said yesterday.
Legislation addressing pharmacy benefit manager Express Scripts’ (ESI) new claims identification requirement for 340B drugs could be introduced in Congress soon, advisers to 340B covered entities said yesterday.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
